- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/333 - Radicals substituted by oxygen or sulfur atoms
Patent holdings for IPC class C07D 207/333
Total number of patents in this class: 160
10-year publication summary
17
|
18
|
15
|
16
|
13
|
9
|
8
|
3
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zydus Lifesciences Limited | 102 |
9 |
Takeda Pharmaceutical Company Limited | 2943 |
8 |
Politecnico di Milano | 826 |
6 |
Janssen Pharmaceutica N.V. | 3612 |
5 |
ViiV Healthcare UK (No. 4) Limited | 25 |
5 |
Centre National de La Recherche Scientifique | 10102 |
4 |
Bayer Pharma AG | 1085 |
4 |
Pirelli Tyre S.p.A. | 1870 |
4 |
The Board of Trustees of the University of Illinois | 2666 |
3 |
Cadila Healthcare Limited | 323 |
3 |
Lupin Limited | 441 |
3 |
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1744 |
3 |
Proteostasis Therapeutics, Inc. | 72 |
3 |
The Trustees of Princeton University | 1169 |
3 |
Vivreon Biosciences, LLC | 3 |
3 |
The Regents of the University of California | 19517 |
2 |
Syngenta Participations AG | 3032 |
2 |
FUJIFILM Corporation | 28805 |
2 |
Board of Trustees of Michigan State University | 1157 |
2 |
Canopy Growth Corporation | 262 |
2 |
Other owners | 84 |